160sek
-6,0 %
Date:2025-11-07Time:14:45:04Latest report:Q2-2025List:First NorthTicker:NANEXA
Market Cap:254 msekEnterprise Value:250 msekNet Sales:14,3 msekEarnings:-37,6 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:1,60
MA50:2,10
MA200:1,86
Price/MA200:-14,0 %
RSI (14):25,0
Price/MA50:-23,7 %

Description

Nanexa is a drug delivery company with a proprietary platform that is used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The PharmaShell process is based on ALD (Atomic Layer Deposition) technology, which encloses pharmaceutical particles with a thin shell and creates opportunities for pharmaceutical companies to develop new products. Nanexa has cooperation with several pharmaceutical companies, mainly around the Nordic market.

Medical Equipment